Oracle’s position as a premier AI infrastructure provider has been bolstered by recent developments at OpenAI, including the $100 million acquisition of Torch and the launch of OpenAI Health. These moves expand OpenAI’s addressable market into healthcare and adjacent industries, driving anticipated demand for Oracle’s cloud compute and networking solutions. With OpenAI representing an estimated 60% of Oracle’s $523 billion remaining performance obligations backlog, any acceleration in OpenAI’s monetization efforts directly underpins Oracle’s revenue visibility for the next several years.

Following a nearly 45% peak-to-trough pullback in 2025, Oracle now trades at approximately 30 times forward earnings—well below the multiples commanded by pure-play AI infrastructure peers. This valuation metric reflects investor caution around Oracle’s debt-financed capex program but contrasts sharply with the company’s execution track record. Oracle is rapidly deploying next-generation GPU clusters built around NVIDIA’s Vera Rubin accelerator chips, leveraging its Oracle Acceleron RoCE fabric to deliver low-latency, high-throughput superclusters for AI model training and inference.

In late December, a group of bondholders filed suit accusing Oracle of failing to disclose the need for significant additional debt issuance to fund its AI data center build-out. While the lawsuit underscores investor concern over Oracle’s total leverage – which rose by nearly 15% year-over-year to support aggressive capex – management’s guidance points to stabilizing free cash flow by mid-2026. Continued deleveraging through incremental cloud software subscription renewals and data center efficiencies could mitigate these legal and credit risks, paving the way for a rerating as execution milestones are met.